867
Views
6
CrossRef citations to date
0
Altmetric
Pancreas

Opportunities of improvement in the management of pancreatic and periampullary tumors

Prospective evaluation of outcome from a multidisciplinary research program

, , , , , , , & show all
Pages 617-625 | Received 06 Dec 2012, Accepted 22 Feb 2013, Published online: 18 Apr 2013

Reference

  • Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg 2007;246:173–80.
  • Bentrem DJ, Brennan MF. Outcomes in oncologic surgery: does volume make a difference? World J Surg 2005;29:1210–16.
  • Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redefining the R1 resection in pancreatic cancer. Br J Surg 2006;93:1232–7.
  • Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138:8–13.
  • Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007;142:761–8.
  • Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 2007;142:20–5.
  • Bilimoria KY, Bentrem DJ, Lillemoe KD, Talamonti MS, Ko CY. Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst 2009;101:848–59.
  • Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 2008;206:833–46.
  • Lim KH, Chung E, Khan A, Cao D, Linehan D, Ben-Josef E, Neoadjuvant therapy of pancreatic cancer: the emerging paradigm? Oncologist 2012;17:192–200.
  • Konstantinidis IT, Warshaw AL, Allen JN, Blaszkowsky LS, Fernandez-del CC, Deshpande V, Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “True” R0 resection? Ann Surg 2013;257:731–6.
  • Boggi U, Del CM, Croce C, Vistoli F, Signori S, Moretto C, Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer. Surgery 2009;146:869–81.
  • Muller SA, Hartel M, Mehrabi A, Welsch T, Martin DJ, Hinz U, Vascular resection in pancreatic cancer surgery: survival determinants. J Gastrointest Surg 2009;13:784–92.
  • Weitz J, Kienle P, Schmidt J, Friess H, Buchler MW. Portal vein resection for advanced pancreatic head cancer. J Am Coll Surg 2007;204:712–16.
  • Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Buchler MW, Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg 2011;254:882–93.
  • Torreggiani WC, Lyburn I, Harris AA, Zwirewich CV. Seeding of pancreatic cancer along the path of a surgical drain: case report and literature review. Can Assoc Radiol J 2000;51:241–3.
  • Marangos IP, Buanes T, Kazaryant A, Rosseland A, Gladhaug I, Mathisen O, Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in high rate of R0 resection and long postoperative survival [in press]. Surgery 2012.
  • Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471–4.
  • Barone JE. Pancreaticoduodenectomy for presumed pancreatic cancer. Surg Oncol 2008;17:139–44.
  • Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neoptolemos JP. Current standards of surgery for pancreatic cancer. Br J Surg 2004;91:1410–27.
  • Hsu CC, Wolfgang CL, Laheru DA, Pawlik TM, Swartz MJ, Winter JM, Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer. J Gastrointest Surg 2012;16:753–61.
  • Yamamoto Y, Sakamoto Y, Ban D, Shimada K, Esaki M, Nara S, Is celiac axis resection justified for T4 pancreatic body cancer? Surgery 2012;151:61–9.
  • Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364:1817–25.
  • Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321:1801–6.
  • Hartwig W, Hackert T, Hinz U, Gluth A, Bergmann F, Strobel O, Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg 2011;254:311–19.
  • Hartwig W, Hackert T, Hinz U, Hassenpflug M, Strobel O, Buchler MW, Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg 2009;250:81–7.
  • Kaneoka Y, Yamaguchi A, Isogai M. Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection. Surgery 2009;145:417–25.
  • Nakao A, Kanzaki A, Fujii T, Kodera Y, Yamada S, Sugimoto H, Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg 2012;255:103–8.
  • Pezzilli R. Total pancreatectomy and quality of life. JOP 2011;12:616.
  • Rehders A, Stoecklein NH, Guray A, Riediger R, Alexander A, Knoefel WT. Vascular invasion in pancreatic cancer: tumor biology or tumor topography? Surgery 2012;152:S143–51.
  • Larssen L, Medhus AW, Hjermstad MJ, Korner H, Glomsaker T, Soberg T, Patient-reported outcomes in palliative gastrointestinal stenting: a Norwegian multicenter study. Surg Endosc 2011;25:3162–9.
  • Nieveen van Dijkum EJ, Kuhlmann KF, Terwee CB, Obertop H, de Haes JC, Gouma DJ. Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg 2005;92:471–7.
  • Pezzilli R, Cariani G, Santini D, Calculli L, Casadei R, Morselli-Labate AM, Therapeutic management and clinical outcome of autoimmune pancreatitis. Scand J Gastroenterol 2011;46:1029–38.
  • Detlefsen S, Zamboni G, Frulloni L, Feyerabend B, Braun F, Gerke O, Clinical features and relapse rates after surgery in type 1 autoimmune pancreatitis differ from type 2: a study of 114 surgically treated European patients. Pancreatology 2012;12:276–83.
  • Pancreatic Section, British Society of Gastroenterology. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut 2005;54:v1–16.
  • Barens SA, Lillemoe KD, Kaufman HS, Sauter PK, Yeo CJ, Talamini MA, Pancreaticoduodenectomy for benign disease 9. Am J Surg 1996;171:131–4.
  • Katz MH, Hu CY, Fleming JB, Pisters PW, Lee JE, Chang GJ. Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer. Arch Surg 2012;147:513–9.
  • Hoem D, Viste A. Improving survival following surgery for pancreatic ductal adenocarcinoma – a ten-year experience. Eur J Surg Oncol 2012;38:245–51.